A polymorphism in the dysbindin gene (DTNBP1) associated with multiple psychiatric disorders including schizophrenia
Open Access
- 9 July 2010
- journal article
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 6 (1) , 41
Abstract
Background: A number of studies have found associations between dysbindin (DTNBP1) polymorphisms and schizophrenia. Recently we identified a DTNBP1 SNP (rs9370822) that is strongly associated with schizophrenia. Individuals diagnosed with schizophrenia were nearly three times as likely to carry the CC genotype compared to the AA genotype. Methods: To investigate the importance of this SNP in the function of DTNBP1, a number of psychiatric conditions including addictive behaviours and anxiety disorders were analysed for association with rs9370822. Results: The DTNBP1 polymorphism was significantly associated with post-traumatic stress disorder (PTSD) as well as nicotine and opiate dependence but not alcohol dependence. Individuals suffering PTSD were more than three times as likely to carry the CC genotype compared to the AA genotype. Individuals with nicotine or opiate dependence were more than twice as likely to carry the CC genotype compared to the AA genotype. Conclusions: This study provides further support for the importance of DTNBP1 in psychiatric conditions and suggests that there is a common underlying molecular defect involving DTNBP1 that contributes to the development of several anxiety and addictive disorders that are generally recognised as separate clinical conditions. These disorders may actually be different expressions of a single metabolic pathway perturbation. As our participant numbers are limited our observations should be viewed with caution until they are independently replicated.Keywords
This publication has 35 references indexed in Scilit:
- Genome-wide approaches to schizophreniaBrain Research Bulletin, 2010
- How Prevalent Are Anxiety Disorders in Schizophrenia? A Meta-Analysis and Critical Review on a Significant AssociationSchizophrenia Bulletin, 2009
- Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expressionHuman Molecular Genetics, 2009
- Neurobehavioral abnormalities in the dysbindin‐1 mutant, sandy, on a C57BL/6J genetic backgroundGenes, Brain and Behavior, 2009
- Dopaminergic mutations: Within‐family association and linkage in multiplex alcohol dependence familiesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patientsSchizophrenia Research, 2008
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- DTNBP1 (Dystrobrevin Binding Protein 1) and Schizophrenia: Association Evidence in the 3′ End of the GeneHuman Heredity, 2007
- Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindinBiochemical and Biophysical Research Communications, 2006
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991